ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,748,379 | +11.0% | 2,723,011 | +14.4% | 5.08% | -23.5% |
| Q2 2023 | $8,782,200 | -7.6% | 2,380,000 | -17.1% | 6.65% | +26.1% |
| Q1 2023 | $9,499,700 | -14.7% | 2,870,000 | 0.0% | 5.27% | -6.8% |
| Q4 2022 | $11,135,600 | +58.9% | 2,870,000 | -0.5% | 5.66% | +120.3% |
| Q3 2022 | $7,007,000 | -11.5% | 2,883,710 | -27.9% | 2.57% | -18.9% |
| Q2 2022 | $7,920,000 | +31.1% | 4,000,000 | +21.2% | 3.17% | +56.8% |
| Q1 2022 | $6,039,000 | +29.8% | 3,300,000 | 0.0% | 2.02% | +57.5% |
| Q4 2021 | $4,653,000 | – | 3,300,000 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |